IRIS
D'ALESSANDRO, MIRIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.919
NA - Nord America 12.276
AS - Asia 7.369
SA - Sud America 1.260
AF - Africa 496
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 35.354
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.959
IT - Italia 4.255
RU - Federazione Russa 3.249
SG - Singapore 2.432
CN - Cina 1.660
IE - Irlanda 1.562
GB - Regno Unito 1.383
BR - Brasile 1.036
VN - Vietnam 940
DE - Germania 829
HK - Hong Kong 752
SE - Svezia 657
FR - Francia 613
FI - Finlandia 480
IN - India 361
KR - Corea 289
ZA - Sudafrica 241
BD - Bangladesh 222
NL - Olanda 206
CA - Canada 173
ES - Italia 139
UA - Ucraina 117
JP - Giappone 110
IQ - Iraq 96
MX - Messico 88
PL - Polonia 86
CZ - Repubblica Ceca 74
CI - Costa d'Avorio 70
TR - Turchia 66
AR - Argentina 64
AT - Austria 54
PK - Pakistan 47
ID - Indonesia 43
EG - Egitto 41
IR - Iran 41
NG - Nigeria 39
EC - Ecuador 35
CH - Svizzera 34
UZ - Uzbekistan 33
KE - Kenya 32
MA - Marocco 32
SA - Arabia Saudita 32
AE - Emirati Arabi Uniti 30
VE - Venezuela 30
PH - Filippine 29
CL - Cile 24
MY - Malesia 21
AU - Australia 20
CO - Colombia 20
IL - Israele 20
JO - Giordania 20
BE - Belgio 19
LT - Lituania 18
PE - Perù 18
PT - Portogallo 17
BG - Bulgaria 14
TN - Tunisia 14
KZ - Kazakistan 13
NP - Nepal 13
PY - Paraguay 13
RO - Romania 13
AZ - Azerbaigian 12
GR - Grecia 12
EE - Estonia 11
HU - Ungheria 11
JM - Giamaica 11
LV - Lettonia 11
OM - Oman 10
PA - Panama 10
KG - Kirghizistan 9
BO - Bolivia 8
DK - Danimarca 8
DO - Repubblica Dominicana 8
GE - Georgia 8
LB - Libano 8
UY - Uruguay 8
AL - Albania 7
CR - Costa Rica 7
DZ - Algeria 7
LK - Sri Lanka 7
MK - Macedonia 7
NO - Norvegia 7
BY - Bielorussia 6
CY - Cipro 6
ET - Etiopia 6
EU - Europa 6
QA - Qatar 6
PS - Palestinian Territory 5
SN - Senegal 5
TH - Thailandia 5
AM - Armenia 4
LA - Repubblica Popolare Democratica del Laos 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
GT - Guatemala 3
GY - Guiana 3
HN - Honduras 3
HR - Croazia 3
LU - Lussemburgo 3
Totale 35.305
Salva come PNG Salva come JPEG
Città #
Dallas 2.667
Dublin 1.531
Singapore 1.515
Southend 1.040
Moscow 989
Ashburn 985
San Jose 902
Santa Clara 831
Milan 823
Hong Kong 697
Chandler 621
Fairfield 461
Hefei 429
Siena 427
Council Bluffs 420
Beijing 411
Los Angeles 398
Munich 374
Lastra a Signa 363
Helsinki 321
Rome 292
Ho Chi Minh City 287
New York 284
Seoul 279
Florence 251
Hanoi 242
Johannesburg 220
Lauterbourg 213
Houston 200
Wilmington 191
Woodbridge 181
Princeton 180
Seattle 177
The Dalles 153
Cambridge 147
São Paulo 112
Chicago 103
Ann Arbor 100
Bengaluru 93
Shanghai 93
Buffalo 86
Orem 81
Frankfurt am Main 78
Tokyo 77
Lappeenranta 73
Warsaw 73
Abidjan 70
London 70
Turku 69
Nuremberg 68
Redondo Beach 67
Fremont 66
Turin 59
Düsseldorf 57
Málaga 57
San Mateo 55
Chennai 54
Portsmouth 54
Boardman 53
Da Nang 53
Jacksonville 52
Figino 51
San Diego 48
Toronto 48
Dong Ket 44
Haiphong 44
Montreal 44
Stockholm 44
Brooklyn 43
Naples 43
Phoenix 43
Atlanta 41
Washington 41
Amsterdam 39
Brno 39
Denver 39
Baghdad 38
Poplar 35
Manchester 34
Abuja 33
Brescia 33
Bologna 32
Boston 32
Paris 30
Rio de Janeiro 30
Tashkent 30
San Francisco 29
Olomouc 28
Vienna 28
Mexico City 27
Mumbai 26
Newark 26
Salt Lake City 25
New Delhi 23
Charlotte 22
Dhaka 22
Zurich 22
Guangzhou 21
Hyderabad 21
Agliana 20
Totale 22.693
Salva come PNG Salva come JPEG
Nome #
A first update on mapping the human genetic architecture of COVID-19 589
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 587
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 505
Genetic mechanisms of critical illness in COVID-19 434
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 426
An explainable model of host genetic interactions linked to COVID-19 severity 375
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 373
Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis 364
Pathogen-sugar interactions revealed by universal saturation transfer analysis 363
A Novel Ultrasonographic Anthropometric-Independent Measurement of Median Nerve Swelling in Carpal Tunnel Syndrome: The "Nerve/Tendon Ratio" (NTR) 323
Peripheral biomarkers' panel for severe COVID-19 patients 321
null 320
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 317
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 308
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 302
POS0871 diagnostic accuracy og power doppler ultrasonography for the diagnosis of idiopathic inflammmatory myopathies 299
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 297
Accuracy of power Doppler ultrasonography in the diagnosis and monitoring of idiopathic inflammatory myopathies 291
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 286
Antithrombin III as predictive indicator of survival in IPF patients treated with Nintedanib: a preliminary study 282
The effect of cigarette smoking on bronchoalveolar lavage protein profiles from patients with different interstitial lung diseases 280
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 270
Adiponectin and leptin levels in idiopathic pulmonary fibrosis: A new method for BAL and serum assessment 264
A Comprehensive Evaluation of Mepolizumab Effectiveness in a Real-Life Setting 262
Prognostic bioindicators in severe COVID-19 patients 257
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes 257
Adaptive immune system in pulmonary sarcoidosis - comparison of peripheral and alveolar biomarkers 256
Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena 252
Serial KL-6 measurements in COVID-19 patients 250
A real-life experience with ImmunoCAP ISAC: the advantages of a new diagnostic method 246
Ceruloplasmin and oxidative stress in severe eosinophilic asthma patients treated with Mepolizumab and Benralizumab 244
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 243
Alveolar nitric oxide is related to periostin levels in idiopathic pulmonary fibrosis 242
BAL Proteomic Signature of Lung Adenocarcinoma in IPF Patients and Its Transposition in Serum Samples for Less Invasive Diagnostic Procedures 235
Alveolar nitric oxide as a biomarker of COVID-19 lung sequelae: A pivotal study 235
AB0611 Neutrophil extracellular traps and interstitial lung disease in ANCA-associated vasculitis: a scoping review 233
NK and NKT-like cells in granulomatous and fibrotic lung diseases 229
Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600II 229
BAL biomarkers’ panel for differential diagnosis of interstitial lung diseases 228
Serum KL-6 concentrations as a novel biomarker of severe COVID-19 227
Galactin-1, 3 and 9: Potential biomarkers in idiopathic pulmonary fibrosis and other interstitial lung diseases 226
Bronchoalveolar lavage and serum KL-6 concentrations in chronic hypersensitivity pneumonitis: correlations with radiological and immunological features 225
Altered serum concentrations of IL-8, IL-32 and IL-10 in patients with lung impairment 6 months after COVID-19 224
BAL and serum multiplex lipid profiling in idiopathic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis 224
Immune-Checkpoint Expression on CD4, CD8 and NK Cells in Blood, Bronchoalveolar Lavage and Lymph Nodes of Sarcoidosis 222
Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder 221
A multicenter approach to evaluate omalizumab effectiveness in Samter’s triad 220
The Role of Urinary Calcium and Chitotriosidase in a Cohort of Chronic Sarcoidosis Patients 216
Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies 215
Idiopathic Pulmonary Fibrosis Serum proteomic analysis before and after nintedanib therapy 215
WES profiling of COVID-19 213
Collagen Type IV Alpha 5 Chain in Bronchiolitis Obliterans Syndrome After Lung Transplant: The First Evidence 212
Inflammatory muscle involvement in systemic vasculitis: A systematic review 210
Whole-genome sequencing reveals host factors underlying critical COVID-19 208
Peripheral Macrovascular Involvement in Systemic Sclerosis: A Cohort Study by Color and Spectral Doppler Ultrasonography 207
Serum amyloid A: A potential biomarker of lung disorders 207
Serum concentrations of Krebs von den Lungen-6 in different COVID-19 phenotypes 203
Systematic review and metanalysis of oncomarkers in ipf patients and serial changes of oncomarkers in a prospective italian real-life case series 202
Alteration of Immune-checkpoint after specific stimulation with CMV antigens in pre-LTx patients 202
Efficacy of baricitinib in treating rheumatoid arthritis: Modulatory effects on fibrotic and inflammatory biomarkers in a real-life setting 201
Protective role of a TMPRSS2 variant on severe COVID-19 outcome in young males and elderly women 200
Clinical and molecular characterization of COVID-19 hospitalized patients 199
Regulatory and Effector Cell Disequilibrium in Patients with Acute Cellular Rejection and Chronic Lung Allograft Dysfunction after Lung Transplantation: Comparison of Peripheral and Alveolar Distribution 199
A Comprehensive Review of Sarcoidosis Diagnosis and Monitoring for the Pulmonologist 199
Anti-Cytosolic 5′-Nucleotidase 1A in the Diagnosis of Patients with Suspected Idiopathic Inflammatory Myopathies: An Italian Real-Life, Single-Centre Retrospective Study 199
Right cardiac involvement in lung diseases: a multimodality approach from diagnosis to prognostication 196
Peripheral and alveolar biomarkers of fibrotic hypersensitivity pneumonitis 195
Serum Proteomic Profile of Asthmatic Patients after Six Months of Benralizumab and Mepolizumab Treatment 195
Effects of rituximab therapy on B cell differentiation and depletion 194
Oxygen Therapy during Exercise in Patients with Interstitial Lung Diseases 192
The role of bDMARDs in idiopathic inflammatory myopathies: A systematic literature review 191
Brain neuronal and glial damage during acute COVID-19 infection in absence of clinical neurological manifestations 190
Regulatory T cell monitoring in severe eosinophilic asthma patients treated with mepolizumab 190
Krebs von den Lungen-6 as biomarker for disease severity assessment in interstitial lung disease: a comprehensive review 185
Metabolic Dysregulation in Idiopathic Pulmonary Fibrosis 185
Peripheral lymphocyte subset monitoring in COVID-19 Italian patients 184
CD103 Expression on Regulatory and Follicular T Cells in Lymph Nodes, Bronchoalveolar Lavage Fluid and Peripheral Blood of Sarcoidosis Patients 184
Serum CD59: a novel biomarker of idiopathic pulmonary fibrosis? 184
Proteomic characterization of idiopathic pulmonary fibrosis patients: stable versus acute exacerbation 183
Prognostic role of KL-6 in lymphangioleiomyomatosis patients 183
Discordant liver fibrosis predictors in virologically suppressed people living with hiv without hepatitis virus infection 183
Efficacy and safety of a step-down regimen of low dosage of glucocorticoids combined with early administration of synthetic or biologic immunosuppressants in anti-synthetase syndrome: A pilot study 182
Common molecular pathways targeted by nintedanib in cancer and IPF: a bioinformatic study 181
Differential redox proteomic profiles of serum from severe asthma patients after one month of Benralizumab and Mepolizumab treatment 181
Characterization of NKG2-A/-C, Kir and CD57 on NK Cells Stimulated with pp65 and IE-1 Antigens in Patients Awaiting Lung Transplant 181
The Effects of Interstitial Lung Diseases on Alveolar Extracellular Vesicles Profile: A Multicenter Study 179
Mepolizumab and Benralizumab in Severe Eosinophilic Asthma: Preliminary Results of a Proteomic Study 179
Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy 179
Clinical, laboratory and ultrasonographic findings at baseline predict long-term outcome of polymyalgia rheumatica: a multicentric retrospective study : Polymyalgia rheumatica predicted by ultrasonographic findings polymyalgia rheumatica outcome predicted early by ultrasound 178
Neutrophil-to-lymphocyte ratio in bronchoalveolar lavage from IPF patients: a novel prognostic biomarker? 177
Utility of serological biomarker' panels for diagnostic accuracy of interstitial lung diseases 176
Bronchoalveolar-Lavage-Derived Fibroblast Cell Line (B-LSDM7) as a new protocol for investigating the mechanisms of idiopathic pulmonary fibrosis 175
Sarcoid Nodule or Lung Cancer? A High-Resolution Computed Tomography-Based Retrospective Study of Pulmonary Nodules in Patients with Sarcoidosis 169
Markers of Bronchiolitis Obliterans Syndrome after Lung Transplant: Between Old Knowledge and Future Perspective 168
Immunologic responses to antifibrotic treatment in IPF patients 167
Cytokine profiles in the detection of severe lung involvement in hospitalized patients with COVID-19: The IL-8/IL-32 axis 165
Exploring the interaction between fractional exhaled nitric oxide and biologic treatment in severe asthma: a systematic review 164
Prevalence of myositis specific and associated antibodies in a cohort of patients affected by idiopathic NSIP and no hint of inflammatory myopathies 162
Long-Term Follow-Up of Patients With Idiopathic Pulmonary Fibrosis Treated With Pirfenidone or Nintedanib: A Real-Life Comparison Study 161
Cytological analysis of bronchoalveolar lavage fluid in asbestos-exposed workers: BALF features in asbestos exposed workers 161
Totale 23.869
Salva come PNG Salva come JPEG
Categoria #
all - tutte 123.424
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 123.424
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.169 160 237 194 146 106 100 87 109 96 286 231 417
2022/20232.800 181 305 334 279 157 479 308 236 176 138 121 86
2023/20243.278 121 95 325 187 177 689 908 166 50 115 135 310
2024/20257.553 629 300 842 417 853 452 416 440 588 364 687 1.565
2025/202617.775 1.173 2.244 2.104 2.064 3.393 645 2.196 539 640 976 634 1.167
2026/2027222 222 0 0 0 0 0 0 0 0 0 0 0
Totale 36.196